WO2022239914A1 - Poudre composite destinée à atténuer la perte de cheveux et composition cosmétique capillaire la contenant - Google Patents
Poudre composite destinée à atténuer la perte de cheveux et composition cosmétique capillaire la contenant Download PDFInfo
- Publication number
- WO2022239914A1 WO2022239914A1 PCT/KR2021/013565 KR2021013565W WO2022239914A1 WO 2022239914 A1 WO2022239914 A1 WO 2022239914A1 KR 2021013565 W KR2021013565 W KR 2021013565W WO 2022239914 A1 WO2022239914 A1 WO 2022239914A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair loss
- hair
- powder
- adenosine
- complex
- Prior art date
Links
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 93
- 208000024963 hair loss Diseases 0.000 title claims abstract description 92
- 239000000843 powder Substances 0.000 title claims abstract description 74
- 230000003676 hair loss Effects 0.000 title claims abstract description 25
- 239000002131 composite material Substances 0.000 title claims abstract description 13
- 210000004209 hair Anatomy 0.000 title claims description 41
- 239000000203 mixture Substances 0.000 title claims description 28
- 239000002537 cosmetic Substances 0.000 title claims description 18
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims abstract description 112
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims abstract description 56
- 229960005305 adenosine Drugs 0.000 claims abstract description 56
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000011570 nicotinamide Substances 0.000 claims abstract description 31
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 30
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 29
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 23
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000004090 dissolution Methods 0.000 claims abstract description 18
- 239000003125 aqueous solvent Substances 0.000 claims abstract description 5
- 230000003752 improving hair Effects 0.000 claims description 67
- 239000002453 shampoo Substances 0.000 claims description 16
- 239000003752 hydrotrope Substances 0.000 claims description 15
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 claims description 15
- 230000006872 improvement Effects 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- 229940089473 isoniacinamide Drugs 0.000 claims description 6
- VFQXVTODMYMSMJ-UHFFFAOYSA-N isonicotinamide Chemical group NC(=O)C1=CC=NC=C1 VFQXVTODMYMSMJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000001256 tonic effect Effects 0.000 claims description 6
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- 239000003595 mist Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 description 33
- 230000000694 effects Effects 0.000 description 19
- 238000001556 precipitation Methods 0.000 description 16
- 238000003860 storage Methods 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 10
- 238000001953 recrystallisation Methods 0.000 description 7
- 230000003779 hair growth Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 238000005185 salting out Methods 0.000 description 5
- 210000004761 scalp Anatomy 0.000 description 5
- 230000002354 daily effect Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 210000003780 hair follicle Anatomy 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 3
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 3
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 229940098448 fibroblast growth factor 7 Drugs 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000000861 blow drying Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000003645 female-pattern hair loss Effects 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000000442 hair follicle cell Anatomy 0.000 description 1
- 230000003165 hydrotropic effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003273 male-pattern hair loss Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- ODLHGICHYURWBS-FOSILIAISA-N molport-023-220-444 Chemical compound CC(O)COC[C@@H]([C@@H]([C@H]([C@@H]1O)O)O[C@@H]2O[C@H]([C@H](O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O3)[C@@H](O)[C@@H]2O)COCC(O)C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@H]3O[C@H]1COCC(C)O ODLHGICHYURWBS-FOSILIAISA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Definitions
- the present invention relates to a complex powder for improving hair loss and a cosmetic composition for hair comprising the same.
- Hair loss refers to a condition in which there is little or no hair in the area where hair should normally exist.
- the causes of hair loss include genetic causes, the action of male hormones, as well as severe causes such as endocrine diseases, nutritional deficiencies, drug use, childbirth, fever, and surgery. It is known that factors such as physical and mental stress are complexly involved to show hair loss symptoms. In recent years, not only male pattern baldness but also female hair loss is on the rise, and the number of people suffering from abnormal scalp and hair symptoms is increasing and their age is also getting lower.
- adenosine has excellent stability and anti-wrinkle effect on the human body, as well as excellent safety on the human body when penetrating into the skin, proving the hair loss improvement and hair growth effect of adenosine, a substance notified as a raw material for wrinkle improvement.
- adenosine has a very low water solubility, recrystallization or precipitation occurs in cosmetic compositions or pharmaceutical compositions, and it is difficult to contain adenosine at high concentrations. Therefore, it is inevitable to be included in a low content of less than the effective concentration in the composition, and there is a limit to implementing a satisfactory effect.
- the present invention has been made to solve the above problems, and an object of the present invention is to provide a complex powder for improving hair loss that can be easily used by rapidly dissolving a high content of adenosine.
- the present invention provides a cosmetic composition for hair comprising the complex powder for improving hair loss.
- the present invention is a complex powder for improving hair loss containing adenosine, niacinamide and cyclodextrin, comprising 10 to 50% by weight of adenosine and 25 to 70% by weight of niacinamide, based on the total weight of the complex powder for improving hair loss.
- adenosine powder for improving hair loss has a dissolution rate of 1 mg/sec or more when 2.5 g is dissolved in 100 g of an aqueous solvent at 25 ° C., providing a complex powder for improving hair loss .
- the adenosine and niacinamide may be included in a weight ratio of 1:1 to 1:3.
- the niacinamide according to an embodiment of the present invention may be isoniacinamide.
- the cyclodextrin according to an embodiment of the present invention may include beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
- the aqueous solvent according to an embodiment of the present invention may include distilled water.
- the complex powder for improving hair loss according to an embodiment of the present invention may further include ethylenediaminetetraacetic acid sodum salt (Disodium EDTA).
- ethylenediaminetetraacetic acid sodum salt Diisodium EDTA
- the present invention provides a cosmetic composition for hair comprising the complex powder for improving hair loss.
- the cosmetic composition for hair may include shampoo, treatment, hair tonic, hair mist, hair essence, hair tonic, hair pack, and hair cream.
- Adenosine may be included in an amount of 0.1 to 5% by weight based on the total weight of the cosmetic composition for hair according to an embodiment of the present invention.
- the present invention comprises the steps of (a) preparing a hydrotrope complex by introducing adenosine, niacinamide and cyclodextrin into a powder mixer and uniformly mixing them under humid conditions; And (b) drying the hydrotrope complex; it provides a method for producing a complex powder for improving hair loss, including.
- the powder mixer of step (a) may be a double cone mixer, a paddle mixer, a V-type mixer, a cone mixer, or a coulter mixer.
- the humidification condition of step (a) may be 80 to 95% relative humidity.
- the hydrotrope complex of step (a) may be an aggregate in which adenosine, niacinamide, and cyclodextrin are aggregated.
- the complex powder for improving hair loss according to the present invention can implement excellent solubility and dissolution rate in water as well as cosmetic compositions for hair such as shampoo.
- the complex powder for improving hair loss according to the present invention is rapidly dissolved in a shampoo used every day in daily life and has excellent usability, and can exhibit an excellent hair loss improvement effect by including a high content of adenosine.
- the cosmetic composition for hair in which the complex powder for improving hair loss according to the present invention is dissolved can maintain excellent stability without precipitation or recrystallization of adenosine even during long-term storage. That is, the complex powder for improving hair loss according to the present invention can satisfy all of excellent hair loss improvement effects, excellent stability, market competitiveness and usability.
- Figure 1 shows the formulation of the skin toner used for solubility evaluation.
- Figure 2 shows the formulation of the shampoo used for solubility evaluation.
- Units used herein without special mention are based on weight, and as an example, the unit of % or ratio means weight% or weight ratio, and unless otherwise defined, weight% means that any one component of the entire composition is included in the composition. It means the weight percent occupied by
- niacinamide means 1,3-niacinamide or 1,4-niacinamide (isoniacinamide).
- the complex powder for improving hair loss according to the present invention may include adenosine, niacinamide and cyclodextrin.
- adenosine Although it has been proven that adenosine has an excellent effect on improving and treating hair loss, recrystallization or precipitation occurs due to the very low solubility of adenosine, and it is difficult to contain a high concentration of adenosine. Therefore, it is inevitable to be included in a low content less than the effective concentration in the product, and there is a limit to implementing a satisfactory effect.
- the complex powder for improving hair loss according to the present invention is one in which the solubility and dissolution rate of adenosine are significantly improved, and a cosmetic composition for hair excellent in both stability and hair loss improving effect can be provided using this.
- the complex powder for improving hair loss may contain 10 to 50% by weight of adenosine, 25 to 70% by weight of niacinamide, and 5 to 45% by weight of cyclodextrin, based on the total weight.
- the adenosine powder for improving hair loss may have a dissolution rate of 1 mg/sec or more when dissolving 2.5 g in 100 g of an aqueous solvent at 25 ° C., specifically, 5 mg/sec or more, or 10 mg/sec or more, It may be, without limitation, 100 mg/sec or less, 50 mg/sec or less, or 20 mg/sec or less.
- the adenosine according to an embodiment of the present invention may be included in 10 to 40% by weight, more preferably 20 to 35% by weight based on the total weight of the complex powder for improving hair loss.
- VEGF vascular endothelial growth factor
- FGF-7 fibroblast growth factor-7
- hair growth It has an excellent effect in helping to thicken the diameter (thickness) of the hair.
- VEGF is an important growth factor that affects hair growth by helping active material exchange between capillaries and peripheral nerve cells in the scalp. It can increase the thickness and distribution of hair by increasing the size and distribution of capillaries in hair follicles and strengthen hair follicles. . That is, by promoting the expression of VEFG, it is possible to improve hair loss by forming new blood vessels around hair follicles and promoting blood circulation.
- FGF-7 is a fibroblast growth factor, which is involved in promoting hair follicle cell differentiation to maintain hair follicles in the growing phase and stimulates hair growth to help improve hair loss.
- the niacinamide according to an embodiment of the present invention may be included in 25 to 70% by weight, preferably 30 to 70% by weight, more preferably 30 to 60% by weight, based on the total weight of the complex powder for improving hair loss.
- the complex powder for improving hair loss according to an embodiment of the present invention may include the adenosine and niacinamide in a weight ratio of 1:1 to 1:3, and especially containing the adenosine and niacinamide in a weight ratio of 1:1 to 1:2.5 desirable.
- the complex powder for improving hair loss includes niacinamide in the above numerical range, thereby improving the solubility of adenosine and at the same time providing a synergistic effect with adenosine in the effect of improving hair loss.
- niacinamide (nicotinamide, nicotinamide, nicotamide) is a generic term for nicotinic acid and nicotinic acid amide, belongs to the vitamin B group, supplies nutrients to the scalp and hair, and prevents oxidation of components. It helps to maintain product stability.
- niacinamide since niacinamide has a hydrotropic property, it can significantly improve the solubility of adenosine by interacting with adenosine and make it possible to contain adenosine in a high concentration in a product.
- the niacinamide according to an embodiment of the present invention may be isoniacinamide in terms of improving the solubility and dissolution rate of adenosine.
- the complex powder for improving hair loss according to the present invention may be advantageous in forming an effective hydrotrope complex with adenosine, and thus, the solubility and dissolution rate of adenosine may be further improved.
- the cyclodextrin according to an embodiment of the present invention may be included in an amount of 5 to 45% by weight, preferably 10 to 45% by weight, more preferably 20 to 40% by weight, based on the total weight of the complex powder for improving hair loss. can be included as
- the cyclodextrin according to an embodiment of the present invention may include beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
- the complex powder for improving hair loss contains cyclodextrin in the above numerical range, thereby realizing a synergistic effect with niacinamide to improve the solubility of adenosine, as well as product stability and hair loss improvement effect can be enhanced at the same time.
- the complex powder for improving hair loss according to the present invention can significantly improve the dissolution rate by forming a hydrotrope complex of adenosine, niacinamide and cyclodextrin, and can prevent precipitation or recrystallization of adenosine during long-term storage. .
- the complex powder for improving hair loss according to an embodiment of the present invention may further include ethylenediaminetetraacetic acid sodum salt (Disodium EDTA, EDTA 2Na) as a stabilizer.
- ethylenediaminetetraacetic acid sodum salt Disodium EDTA, EDTA 2Na
- the complex powder for improving hair loss according to the present invention has the above-described structural characteristics, so that the solubility and dissolution rate of adenosine can be remarkably improved.
- the solubility of adenosine in water at room temperature (25 ° C.) has been known to be 0.26% by weight, but the solubility of adenosine in water at room temperature (25 ° C.) in the complex powder for improving hair loss according to the present invention is 1% by weight. up to, and no precipitation or recrystallization occurs.
- the complex powder for improving hair loss has very high solubility in hair cosmetic compositions such as shampoo, treatment, hair tonic, hair mist, hair essence, hair tonic, hair pack, and hair cream as well as water. great.
- the cosmetic composition for hair may include 0.1 to 5% by weight of adenosine, preferably 0.5 to 3% by weight, more preferably 0.5 to 2% by weight based on the total weight of the composition.
- the complex powder for improving hair loss according to the present invention can be easily used by dissolving in a shampoo used every day in daily life, and thus not only has excellent usability, but can also contain a high content of adenosine, thereby exhibiting an excellent hair loss improvement effect.
- the cosmetic composition for hair in which the complex powder for improving hair loss according to the present invention is dissolved can maintain excellent stability without precipitation or recrystallization even during long-term storage. That is, the complex powder for improving hair loss according to the present invention can satisfy all of excellent hair loss improvement effects, excellent stability, market competitiveness and usability.
- the present invention comprises the steps of (a) preparing a hydrotrope complex by introducing adenosine, niacinamide and cyclodextrin into a powder mixer and uniformly mixing them under humid conditions; and (b) drying the hydrotrope complex.
- the step (a) is a step of uniformly mixing the raw materials before humidifying conditions, and may include mixing the raw materials in a powder mixer and mixing them evenly at room temperature (25 ° C.) for 30 minutes to 2 hours.
- the powder mixer is not particularly limited as long as it is a powder mixer commonly used in the art, but as a non-limiting example, it may be a double cone mixer, a paddle mixer, a V-type mixer, a cone mixer, or a coulter type mixer, and a double cone mixer it is more preferable
- the humidification conditions of the step (a) according to an embodiment of the present invention may be performed at a relative humidity of 80 to 95%, more specifically, at 85 to 95%, and at room temperature (25 ° C.) for 1 hour to 3 hours
- a hydrotrope complex can be formed by uniformly blending.
- the hydrotrope complex prepared in step (a) may be an aggregate in which adenosine, niacinamide, and cyclodextrin are aggregated.
- the complex powder for improving hair loss according to an embodiment of the present invention can significantly improve the solubility and dissolution rate of adenosine by forming a hydrotrope complex through the step (a).
- the drying method of the step (b) according to an embodiment of the present invention is not particularly limited, and a known method such as blow drying or reduced pressure drying may be used, and it is more preferable to use reduced pressure drying.
- the drying temperature may be 30 to 150 °C, preferably 40 to 120 °C, and more preferably 50 to 100 °C.
- the drying time is not particularly limited, but the complex powder for improving hair loss can be sufficiently dried by performing the drying for 2 to 5 hours.
- each raw material was put into a double cone mixer and mixed at 10 rpm for 120 minutes at room temperature (25 ° C.). Thereafter, steam was sprayed and mixed at 10 rpm for 2 hours under a relative humidity of 90% to prepare a hydrotrope composite, and then dried at 50 ° C. for 3 hours under reduced pressure to prepare a composite powder for improving hair loss.
- each raw material was put into a double cone mixer and dry blended at room temperature (25 ° C.) at 10 rpm for 2 hours to prepare a composite powder for improving hair loss.
- Example 1 Example 2 Example 3 Example 4 Example 5 dissolution rate ⁇ ⁇ ⁇ ⁇ ⁇ Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 Comparative Example 5 Comparative Example 6 dissolution rate ⁇ X X ⁇ ⁇ X
- the complex powder for improving hair loss according to the present invention was remarkably excellent in both dissolution rate and solubility. Specifically, as shown in Table 2, the composite powders for improving hair loss of Examples 1 to 5 had a very good dissolution rate in distilled water and were completely dissolved (2.5 wt%) within 150 seconds. On the other hand, the complex powders for improving hair loss of Comparative Examples 1 to 6 took 5 or 10 minutes or more to completely dissolve.
- the composite powders for improving hair loss of Examples 1 to 5 had excellent solubility in distilled water as well as skin toner and shampoo, and were thus treated at 4 ° C, 25 ° C, 50 ° C, cycle (- 18 °C -> 25 °C -> 40 °C -> 25 °C -> -18 °C Maintained for 24 hours at each temperature, 1 hour required for changing temperature conditions) Even when stored for 4 weeks, no precipitation occurred.
- Comparative Examples 1 to 6 it was found that precipitation occurred even under high temperature (50 °C) conditions, resulting in significantly reduced product stability.
- the complex powder for improving hair loss according to the present invention can be easily used by dissolving in a shampoo used every day in daily life, and thus not only has excellent usability, but also can exhibit an excellent hair loss improvement effect by including a high content of adenosine.
- the cosmetic composition for hair in which the complex powder for improving hair loss according to the present invention is dissolved can maintain excellent stability without precipitation or recrystallization even during long-term storage. That is, the complex powder for improving hair loss according to the present invention can satisfy all of excellent hair loss improvement effects, excellent stability, market competitiveness and usability.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
Abstract
La présente invention se rapporte à une poudre composite, comprenant de l'adénosine, du niacinamide et de la cyclodextrine, destinée à atténuer la perte de cheveux. En particulier, la poudre composite destinée à atténuer la perte de cheveux comprend de 10 à 50 % en poids d'adénosine, de 25 à 70 % en poids de niacinamide, et de 5 à 45 % en poids de cyclodextrine par rapport au poids total de cette dernière, et la poudre d'adénosine destinée à atténuer la perte de cheveux peut avoir un taux de dissolution de 1 mg/sec ou plus lorsque 2,5 g de cette dernière sont dissous à 25 °C dans 100 g d'un solvant aqueux.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210061995A KR102337124B1 (ko) | 2021-05-13 | 2021-05-13 | 탈모 개선용 복합 파우더 및 이를 포함하는 모발용 화장료 조성물 |
KR10-2021-0061995 | 2021-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022239914A1 true WO2022239914A1 (fr) | 2022-11-17 |
Family
ID=78865300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2021/013565 WO2022239914A1 (fr) | 2021-05-13 | 2021-10-05 | Poudre composite destinée à atténuer la perte de cheveux et composition cosmétique capillaire la contenant |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102337124B1 (fr) |
WO (1) | WO2022239914A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116421491A (zh) * | 2023-05-30 | 2023-07-14 | 广州市名嫡化妆品有限公司 | 腺苷水性组合物、腺苷溶液及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0175934B1 (ko) * | 1990-03-27 | 1999-03-20 | 치에시 파올로 | 피록시캄/사이클로덱스트린 복합체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
WO2008088816A1 (fr) * | 2007-01-18 | 2008-07-24 | Pgxhealth, Llc | Formulations de dérivé d'adénosine pour l'imagerie médicale |
US20140107059A1 (en) * | 2012-10-12 | 2014-04-17 | L'oreal S.A. | Compositions containing adenosine or an adenosine analogue and hydrotropes for cosmetic use |
KR20150092102A (ko) * | 2012-10-12 | 2015-08-12 | 로레알 | 적어도 하나의 하이드로트로프 및 적어도 하나의 활성제을 포함하는 화장용 조성물 |
US20190159989A1 (en) * | 2017-11-30 | 2019-05-30 | L'oreal | Aqueous compositions with mangiferin for cosmetic applications |
-
2021
- 2021-05-13 KR KR1020210061995A patent/KR102337124B1/ko active IP Right Grant
- 2021-10-05 WO PCT/KR2021/013565 patent/WO2022239914A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0175934B1 (ko) * | 1990-03-27 | 1999-03-20 | 치에시 파올로 | 피록시캄/사이클로덱스트린 복합체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
WO2008088816A1 (fr) * | 2007-01-18 | 2008-07-24 | Pgxhealth, Llc | Formulations de dérivé d'adénosine pour l'imagerie médicale |
US20140107059A1 (en) * | 2012-10-12 | 2014-04-17 | L'oreal S.A. | Compositions containing adenosine or an adenosine analogue and hydrotropes for cosmetic use |
KR20150092102A (ko) * | 2012-10-12 | 2015-08-12 | 로레알 | 적어도 하나의 하이드로트로프 및 적어도 하나의 활성제을 포함하는 화장용 조성물 |
US20190159989A1 (en) * | 2017-11-30 | 2019-05-30 | L'oreal | Aqueous compositions with mangiferin for cosmetic applications |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116421491A (zh) * | 2023-05-30 | 2023-07-14 | 广州市名嫡化妆品有限公司 | 腺苷水性组合物、腺苷溶液及其制备方法和应用 |
CN116421491B (zh) * | 2023-05-30 | 2023-11-10 | 广州市名嫡化妆品有限公司 | 腺苷水性组合物、腺苷溶液及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
KR102337124B1 (ko) | 2021-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012026708A2 (fr) | Composition pour empêcher la chute des cheveux, possédant une excellente fonction de coiffage, et tonique capillaire la contenant | |
WO2012002724A2 (fr) | Procédé de préparation d'une composition fortifiante pour cheveux et cuir chevelu présentant une efficacité accrue sous l'effet de la présence d'une huile essentielle | |
WO2022239914A1 (fr) | Poudre composite destinée à atténuer la perte de cheveux et composition cosmétique capillaire la contenant | |
EP0393445A2 (fr) | Utilisation de peptides inhibiteurs de la renine contre les rétrovirus | |
WO2011013979A2 (fr) | Composition contenant du venin dabeille en tant que substance active pour prévenir et traiter lacné | |
WO2010062103A9 (fr) | Composition topique pour la peau et son procédé de préparation | |
WO2017057868A1 (fr) | Composition modelable de soin des cheveux | |
WO2020218888A1 (fr) | Composition cosmétique pour le blanchiment de la peau contenant de nouvelles lactobacillus rhamnosus lm1011 en tant que principe actif | |
WO2023074990A1 (fr) | Procédé de préparation d'une composition cosmétique dépilatoire facile à préparer en formulations présentant diverses viscosités | |
WO2017069390A1 (fr) | Composition destinée à la prévention ou à la suppression de la xylostomiase | |
WO2019177301A1 (fr) | Composition pour prévenir la perte de cheveux et favoriser la pousse de cheveux et procédé pour sa préparation | |
EP0591378B1 (fr) | Procede de prevention et de traitement de l'alopecie induite par chimiotherapie | |
CN106727283A (zh) | 一种治疗面部痤疮的甲硝唑红霉素复方软膏及其制备方法 | |
WO2020111757A1 (fr) | Composition contenant de la quercétine, de la génistéine et de l'acide alpha-lipoïque, pour soulager la peau acnéique | |
WO2011126189A1 (fr) | Composition de prévention de la chute des cheveux et de stimulation de la croissance des cheveux | |
CN112121105B (zh) | 一种宠物用漱口水喷雾剂及其制备方法 | |
WO2016159537A1 (fr) | Dérivé de phytospingosine et composition le contenant | |
JP2007056219A (ja) | 抗酸化組成物 | |
WO2021112266A1 (fr) | Additif alimentaire pour animaux permettant de réduire le stress oxydatif et d'améliorer l'efficacité de l'alimentation, et son procédé de production | |
WO2022019573A1 (fr) | Composition pour prévenir la chute de cheveux ou favoriser la pousse de cheveux comprenant un extrait de la partie aérienne de carottes | |
WO2018207985A1 (fr) | Composition cosmétique de masque de beauté à changement de couleur en deux étapes et son procédé de préparation | |
WO2017057919A1 (fr) | Composition antibactérienne comprenant de l'acide saccharique et un flavonoïde | |
WO2021010604A1 (fr) | Composition cosmétique comprenant des microsphères contenant une concentration élevée d'oxygène et son procédé de préparation | |
AU2021106478A4 (en) | Vitamin D3 Compositions | |
WO2018030560A1 (fr) | Composition pour prévenir, améliorer ou traiter la perte des cheveux, comprenant de l'acide désoxycholique comme principe actif |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21942062 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21942062 Country of ref document: EP Kind code of ref document: A1 |